For research use only. Not for therapeutic Use.
Tulisokibart(CAT: I040654) is a humanized monoclonal antibody designed to target interleukin-21 receptor (IL-21R), a key mediator in immune signaling pathways involved in inflammation and autoimmunity. By inhibiting IL-21R, Tulisokibart modulates immune cell activation and cytokine production, making it a promising candidate for the treatment of autoimmune diseases such as lupus, rheumatoid arthritis, and inflammatory bowel disease. It is currently under investigation in preclinical and clinical research for its immunomodulatory properties.
| CAS Number | 2648504-55-4 |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
